Chemistry:Eticyclidine
| Clinical data | |
|---|---|
| ATC code |
|
| Legal status | |
| Legal status |
|
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider |
|
| UNII | |
| KEGG |
|
| ChEMBL | |
| Chemical and physical data | |
| Formula | C14H21N |
| Molar mass | 203.329 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
| (verify) | |
Eticyclidine (PCE, CI-400) is a dissociative anesthetic drug with hallucinogenic effects. It is similar in effects to phencyclidine but is slightly more potent. PCE was developed by Parke-Davis in the 1970s and evaluated for anesthetic potential under the code name CI-400,[1] but research into PCE was not continued after the development of ketamine, a similar drug with more favourable properties.[2] PCE is slightly more potent than PCP and has similar effects, but its unpleasant taste and tendency to cause nausea made it less accepted by users.[citation needed] Due to its similarity in effects to PCP, PCE was placed into the Schedule 1 list of illegal drugs in the 1970s, although it was only briefly abused in the 1970s and 1980s and is now little known.
See also
References
- ↑ "Observation on two psychotomimetic drugs of piperidine derivation--CI 395 (sernyl) and CI 400". The American Journal of Psychiatry 116 (9): 843–4. March 1960. doi:10.1176/ajp.116.9.843. PMID 14416411.
- ↑ "1-Phenycycloalkylamine derivatives. II. Synthesis and pharmacological activity". Journal of Medicinal Chemistry 12 (3): 473–7. May 1969. doi:10.1021/jm00303a030. PMID 4977945.
| Inhalational | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Injection |
| ||||||||||||
| |||||||||||||
| D1-like |
| ||||
|---|---|---|---|---|---|
| D2-like |
| ||||
| AMPAR |
|
|---|---|
| KAR |
|
| NMDAR |
|
0.00 ![]() ![]() ![]() ![]() (0 votes) |
